{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:23:25Z","timestamp":1791890605552,"version":"4.3.4"},"reference-count":72,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2019,1,31]]},"DOI":"10.2217\/fon-2018-0371","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T10:20:17Z","timestamp":1537870817000},"page":"257-269","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":40,"title":["Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia"],"prefix":"10.1080","volume":"15","author":[{"given":"Carolina","family":"Pavlovsky","sequence":"first","affiliation":[{"name":"Department of Hematology Oncology,\u00a0Fundaleu Hospitalization & Clinical Research Center, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyee","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, University of South Florida\/Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetasi","family":"Talati","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, University of South Florida\/Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pinilla-Ibarz","sequence":"additional","affiliation":[{"name":"Department of Malignant Hematology,\u00a0Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr060"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441402"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511592"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8899"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.134"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7162"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0704"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-199380"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-529008"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.118588"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-627935"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-052373"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190801896103"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055229"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-073528"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-351403"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-261586"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29646"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055104"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-636548"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.25.18_suppl.7006"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-012-0247-7"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000403"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404318"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70342-X"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402741"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006825"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm100395q"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092146"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.09.028"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0259"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8853"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2007.00556.x"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205127"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3240-x"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv951"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306494"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2238-9"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.132845"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00127-1"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00207-7"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00080-2"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"e_1_3_2_52_1","article-title":"Comparison of PACE clinic trial vs. real-world ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients","author":"Mauro MJ","year":"2016","unstructured":"Mauro MJ , McGarryLJ, YangM, LustgartenS, HuangH. Comparison of PACE clinic trial vs. real-world ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients. EHA Learning Center Abstract E1108 (2016).","journal-title":"EHA Learning Center"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.145623"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-466482"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.7013"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.99.99"},{"key":"e_1_3_2_57_1","unstructured":"ClinicalTrials.gov Identifier NCT02776605. Ponatinib with chemotherapy for young adults Ph positive acute lymphoblastic leukemia (2016). https:\/\/ClinicalTrials.gov\/show\/NCT02776605"},{"key":"e_1_3_2_58_1","unstructured":"ClinicalTrials.gov Identifier NCT01641107. Phase II front-line ponatinib in adult Philadelphia+\/BCR-ABL+ acute lymphoblastic leukemia (2012). https:\/\/ClinicalTrials.gov\/show\/NCT01641107"},{"key":"e_1_3_2_59_1","unstructured":"ClinicalTrials.gov Identifier NCT01424982. Hyper-CVAD and ponatinib in Ph-Positive and\/or BCR-ABL positive acute lymphoblastic leukemia (ALL) (2011). https:\/\/ClinicalTrials.gov\/show\/NCT01424982"},{"key":"e_1_3_2_60_1","unstructured":"ClinicalTrials.gov Identifier NCT03147612. Study of the combination of low-intensity chemotherapy and ponatinib in patients with philadelphia chromosome (Ph)-positive and\/or BCR-ABL positive acute lymphoblastic leukemia (ALL) (2017). https:\/\/ClinicalTrials.gov\/show\/NCT03147612"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.07.088"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30558"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.7048"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.07.007"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1783.1783"},{"key":"e_1_3_2_66_1","unstructured":"ClinicalTrials.gov Identifier NCT02467270. Ponatinib in participants with resistant chronic phase chronic myeloid leukemia (CML) to characterize the efficacy and safety of a range of doses (2015). https:\/\/ClinicalTrials.gov\/show\/NCT02467270"},{"key":"e_1_3_2_67_1","unstructured":"ClinicalTrials.gov Identifier NCT02398825. Activity and risk profile of ponatinib in chronic phase patients with chronic myeloid leukemia resistant to imatinib (2015). https:\/\/ClinicalTrials.gov\/show\/NCT02398825"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.110"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.006"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-660977"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv110"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx236"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.14"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21702"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2018-0371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:44:04Z","timestamp":1719125044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2018-0371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,1,31]]}},"alternative-id":["10.2217\/fon-2018-0371"],"URL":"https:\/\/doi.org\/10.2217\/fon-2018-0371","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}